![Loss of Rai1 enhances hippocampal excitability and epileptogenesis in mouse models of Smith–Magenis syndrome | PNAS Loss of Rai1 enhances hippocampal excitability and epileptogenesis in mouse models of Smith–Magenis syndrome | PNAS](https://www.pnas.org/cms/10.1073/pnas.2210122119/asset/98588602-21a5-4c93-97c7-c8d1b417251d/assets/images/large/pnas.2210122119fig01.jpg)
Loss of Rai1 enhances hippocampal excitability and epileptogenesis in mouse models of Smith–Magenis syndrome | PNAS
![Biomedicines | Free Full-Text | HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy Biomedicines | Free Full-Text | HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy](https://pub.mdpi-res.com/biomedicines/biomedicines-11-00088/article_deploy/html/images/biomedicines-11-00088-g001.png?1672311056)
Biomedicines | Free Full-Text | HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
![Corticotropin-Releasing Factor Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure | eNeuro Corticotropin-Releasing Factor Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure | eNeuro](https://www.eneuro.org/content/7/2/ENEURO.0420-19.2020/F1.large.jpg)
Corticotropin-Releasing Factor Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure | eNeuro
![TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients](https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/iort/540-targit-a-randomised-clinical-phase-iii-trial/targit-a-sperck-pdf-preview-540.jpg)
TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients
![TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients](https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/iort/540-targit-a-randomised-clinical-phase-iii-trial/540-targit_download_preview_169.jpg/_jcr_content/renditions/original./540-targit_download_preview_169.jpg)
TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients
![Antioxidants | Free Full-Text | Exercise Restores Hypothalamic Health in Obesity by Reshaping the Inflammatory Network Antioxidants | Free Full-Text | Exercise Restores Hypothalamic Health in Obesity by Reshaping the Inflammatory Network](https://www.mdpi.com/antioxidants/antioxidants-12-00297/article_deploy/html/images/antioxidants-12-00297-g001.png)
Antioxidants | Free Full-Text | Exercise Restores Hypothalamic Health in Obesity by Reshaping the Inflammatory Network
Saif Al Suwaidi on LinkedIn: Anybody can become angry-that is easy; but to be angry with the right… | 12 comments
![The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a](https://journals.asm.org/cms/asset/d1527f2f-ee12-4e4f-b8b1-1afd01f13477/jvi.2022.96.issue-24.cover.gif)